Company intelligence / Profile preview

Melody International

Takamatsu, Kagawa, Japanmelodyi.net ↗

Ownership: Private
Development stage: Commercial

Overview

Melody International has developed a portable, wireless fetal monitor ("iCTG") integrated with a cloud-based perinatal e-health platform ("Melody i"). The system enables real-time remote supervision of pregnant women by healthcare professionals. It is widely used across Japanese hospitals and has been deployed internationally, including Brazil. The technology is validated clinically for high-risk pregnancies and rural/underserved populations. Regulatory approvals include Japan PMDA and Thai FDA; US FDA submission planned.

Therapeutic areas: Women's Health
Modalities: DeviceNon-pharmacological therapy (remote monitoring)IoMT platform
Industry: Physiological Monitoring

Partnerships

Jameel HealthWellesta

Beyond the preview

Go deeper on Melody International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melody International.

Explore the full profile